Skip to main content
OpenTrials

Clinical trial condition

Carnitine-acylcarnitine Translocase (CACT) Deficiency

Explore clinical trials studying Carnitine-acylcarnitine Translocase (CACT) Deficiency. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Carnitine-acylcarnitine Translocase (CACT) Deficiency trial results

Completed

Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD) Extension Study for Subjects Previously Enrolled in Triheptanoin Studies

NCT02214160

Conditions
Carnitine Palmitoyltransferase (CPT I or CPT II) Deficiency, Carnitine-acylcarnitine Translocase (CACT) Deficiency, Long-chain 3-hydroxy-acyl-CoA Dehydrogenase (LCHAD) Deficiency, +3 more
Locations
  • University of California San Francisco San Francisco, California, United States
  • Children's National Health System Washington D.C., District of Columbia, United States
  • University of South Florida Tampa, Florida, United States
  • Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States
View Trial Details

Related conditions